Triple
T16851819
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | GILD |
E409692
|
entity |
| Predicate | issuerCEO |
P44300
|
FINISHED |
| Object |
Daniel O’Day
Daniel O’Day is a biopharmaceutical executive best known as the chief executive officer of Gilead Sciences.
|
E1236231
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69d88395e6c88190b22730f335107c14 |
elicitation | completed |
| NER | batch_69e3b379b8fc81908d8bc9950c7f8bad |
ner | completed |
| NED1 | batch_6a00bb216fac81909d401c6b9911d1e0 |
ned_source_triple | completed |
| NED2 | batch_6a00bc3a4b888190bd190b9330e2777d |
ned_description | completed |
| NEDg | batch_6a00bb9b2b1881908f9f5c3dd1a2d500 |
nedg | completed |
Created at: April 10, 2026, 5:24 a.m.